,,ii  #aahth ,,congress  #b;d ,session  
,s4 #ebee  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,september #be1
 #bjbd,ms4 ,ernst introduced the        
following bill2 which was read twice and
 referred to the ,committee on ,homeland
 ,security and ,governmental ,affairs   
,a ,,bill  ,to require the ,director of 
the ,office of ,management and ,budget  
to submit to ,congress an annual report 
on biomedical research funded by the    
,united ,states and performed in ,china4
  #a4 ,short title ,this ,act may be    
cited as the ,chinese ,laboratory       
,accountability and ,watchful ,spending 
,act of #bjbd or the ,,claws ,act of    
#bjbd4  #b4 ,annual report on           
federally-funded biomedical research in 
china  7a7 ,definitions ,in this        
section3 7#a7 ,covered agency ,the term 
covered agency means-- 7,a7 an          
,executive agency1 as defined in section
 #aje of title #e1 ,united ,states      
,code2 and  7,b7 an independent         
regulatory agency1 as defined in section

 #cejb of title #dd1 ,united ,states    
,code4  7#b7 ,covered project ,the term 
covered project means a project-- 7,a7  
funded by a covered agency2 and  7,b7   
that is awarded directly or indirectly  
through a grant1 contract1 other        
transaction agreement1 subaward1        
cooperative agreement1 or any other form
 of assistance to an entity that-- 7i7  
is located in ,china2 or  7ii7 performs 
the project in whole or in part in      
,china4  7#c7 ,project ,the term project
 means biomedical research or           
experimentation conducted for the       
identification1 control1 treatment1 and 
prevention of human or animal diseases1 
including the testing of any drug1      
biological product1 device1 vaccine1    
vaccine adjuvant1 antiviral1 or         
diagnostic test4  7b7 ,requirement ,not 
later than #a year after the date of    
enactment of this ,act1 the ,director of
 the ,office of ,management and ,budget 
shall issue guidance requiring covered  
agencies to annually include in a report

 described in paragraph 7#b7 of section 
#ceaf7;a7 of title #ca1 ,united ,states 
,code1 or a consolidated report         
described in paragraph 7#a7 of such     
section1 information relating to each   
covered project of the covered agency1  
which shall include a detailed          
description of the covered project1     
including-- 7#a7 the purpose of the     
covered project2  7#b7 whether the      
covered project involves -- 7,a7        
pathogens with pandemic potential2  7,b7
 biological select agents and toxins2   
7,c7 dual use research of concern2  7,d7
 human or animal subjects2 and  7,e7    
classified research2  7#c7 each location
 where the covered project is carried   
out and1 if applicable-- 7,a7 whether   
the location is subject to the          
jurisdiction or control of1 or operates 
on behalf of1 ,china2 and  7,b7 whether 
the location engages in joint research  
with1 is supported by1 or is affiliated 
with the military1 security forces1 or  
intelligence agencies of ,china2  7#d7  

if applicable1 the rationale for        
conducting the covered project in       
,china2  7#e7 the contract or award     
number of the covered project2  7#f7    
each covered agency or subagency funding
 the covered project2  7#g7 each primary
 contractor1 subcontractor1 grant       
recipient1 and subgrant recipient of the
 covered project2  7#h7 the start date  
of the covered project2  7#i7 the       
current expected date for completion of 
the covered project2  7#aj7 the cost of 
the covered project during the previous 
fiscal year2  7#aa7 the total cost of   
the covered project since inception2    
7#ab7 a description of specific steps   
taken to ensure research security of the
 covered project2 and  7#ac7 any        
noncompliance with respect to the       
covered project documented by the       
covered agency during the reporting     
period4